Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review
MetadataShow full item record
AbstractBackground and Objective: Patient-centered care (PCC) is crucial for value-based care. We aimed to assess PCC dimensions addressed in hepatitis C virus direct-acting antiviral treatment delivery to people who inject drugs. Methods: We conducted a scoping review to identify the studies that described hepatitis C virus treatment delivery to people who inject drugs in the direct-acting antiviral treatment era. We analyzed the included studies against eight PCC dimensions: (1) access to care; (2) coordination and integration of care; (3) continuity and translation; (4) physical comfort; (5) information, education, and communication; (6) emotional support; (7) involvement of family and friends; and (8) respect for individual patient preferences, perceived needs, and values. Additionally, we assessed the use of patient-centered terminology and the recognition of PCC importance and its relevance to treatment outcomes. Results: None of the identified 36 studies addressed all PCC dimensions (highest seven, lowest two). Our findings revealed that PCC dimensions are prioritized differently and addressed using different approaches and strategies. Studies that used PCC terminology referred to personalized activities, which does not imply comprehensive PCC. About one-third of the studies acknowledged the importance of patient centeredness and two-thirds recognized its relevance to treatment outcomes. Conclusions: Our findings suggest more engagement of people who inject drugs and comprehensive involvement of their families and friends in hepatitis C virus treatment journey, decisions, and outcomes. The recognition of PCC importance and its relevance to treatment outcomes in the analyzed studies emphasizes the need for more patient-centered hepatitis C virus treatment for people who inject drugs. © 2020, The Author(s).
KeywordHepatitis C, Chronic--therapy
Patient Outcome Assessment
Substance Abuse, Intravenous
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14656
- 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
- Authors: Tsui JI, Barry MP, Austin EJ, Sweek EW, Tung E, Hansen RN, Ninburg M, Scott JD, Glick SN, Williams EC
- Issue date: 2021 Aug 12
- "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
- Authors: Goodyear T, Ti L, Carrieri P, Small W, Knight R
- Issue date: 2020 Jul
- Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C.
- Authors: Dore GJ, Valerio H, Grebely J
- Issue date: 2020 Oct
- Peer to peer communication about hepatitis C treatment amongst people who inject drugs: A longitudinal qualitative study.
- Authors: Goutzamanis S, Doyle JS, Horyniak D, Higgs P, Hellard M, TAP study group.
- Issue date: 2021 Jan
- Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.
- Authors: Corcorran MA, Tsui JI, Scott JD, Dombrowski JC, Glick SN
- Issue date: 2021 Mar 1